spacer
spacer
Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Cell cycle PDB id
1z2b
Jmol
Contents
Protein chains
427 a.a. *
419 a.a. *
124 a.a. *
Ligands
GTP ×2
GDP ×2
CN2 ×2
VLB
Metals
_MG ×2
* Residue conservation analysis
PDB id:
1z2b
Name: Cell cycle
Title: Tubulin-colchicine-vinblastine: stathmin-like domain complex
Structure: Tubulin alpha chain. Chain: a, c. Tubulin beta chain. Chain: b, d. Rb3 stathmin-like domain 4. Chain: e. Synonym: stathmin-like protein b3, rb3-sld. Engineered: yes
Source: Bos taurus. Cattle. Organism_taxid: 9913. Organ: brain. Other_details: brain. Rattus norvegicus. Norway rat. Organism_taxid: 10116. Gene: stmn4.
Biol. unit: Pentamer (from PQS)
Resolution:
4.10Å     R-factor:   0.212     R-free:   0.269
Authors: B.Gigant,C.Wang,R.B.G.Ravelli,F.Roussi,M.O.Steinmetz,P.A.Cur A.Sobel,M.Knossow
Key ref:
B.Gigant et al. (2005). Structural basis for the regulation of tubulin by vinblastine. Nature, 435, 519-522. PubMed id: 15917812 DOI: 10.1038/nature03566
Date:
08-Mar-05     Release date:   31-May-05    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
No UniProt id for this chain
Protein chains
Pfam   ArchSchema ?
Q6B856  (TBB2B_BOVIN) -  Tubulin beta-2B chain
Seq:
Struc:
445 a.a.
419 a.a.*
Protein chain
Pfam   ArchSchema ?
P63043  (STMN4_RAT) -  Stathmin-4
Seq:
Struc:
189 a.a.
124 a.a.*
Key:    PfamA domain  Secondary structure
* PDB and UniProt seqs differ at 4 residue positions (black crosses)

 Gene Ontology (GO) functional annotation 
  GO annot!
  Cellular component     protein complex   4 terms 
  Biological process     intracellular signal transduction   6 terms 
  Biochemical function     structural molecule activity     4 terms  

 

 
DOI no: 10.1038/nature03566 Nature 435:519-522 (2005)
PubMed id: 15917812  
 
 
Structural basis for the regulation of tubulin by vinblastine.
B.Gigant, C.Wang, R.B.Ravelli, F.Roussi, M.O.Steinmetz, P.A.Curmi, A.Sobel, M.Knossow.
 
  ABSTRACT  
 
Vinblastine is one of several tubulin-targeting Vinca alkaloids that have been responsible for many chemotherapeutic successes since their introduction in the clinic as antitumour drugs. In contrast with the two other classes of small tubulin-binding molecules (Taxol and colchicine), the binding site of vinblastine is largely unknown and the molecular mechanism of this drug has remained elusive. Here we report the X-ray structure of vinblastine bound to tubulin in a complex with the RB3 protein stathmin-like domain (RB3-SLD). Vinblastine introduces a wedge at the interface of two tubulin molecules and thus interferes with tubulin assembly. Together with electron microscopical and biochemical data, the structure explains vinblastine-induced tubulin self-association into spiral aggregates at the expense of microtubule growth. It also shows that vinblastine and the amino-terminal part of RB3-SLD binding sites share a hydrophobic groove on the alpha-tubulin surface that is located at an intermolecular contact in microtubules. This is an attractive target for drugs designed to perturb microtubule dynamics by interfacial interference, for which tubulin seems ideally suited because of its propensity to self-associate.
 
  Selected figure(s)  
 
Figure 1.
Figure 1: The vinblastine-binding site. a, The location of vinblastine in (Tc)[2]R. (Tc)[2]R-bound vinblastine (Vlb, cyan) is shown as a space-filling model; the complex consists of RB3-SLD and two tubulin heterodimers, with colchicine (Col, yellow) bound to the -subunits at the interface with the -subunit. b, Left: chemical formula of vinblastine. Right: [a]-weighted F [obs] - F [calc] omit map of vinblastine-soaked (Tc)[2]R crystals contoured at 3.5 (magenta) overlapped with vinblastine; the difference electron density map between a C12'-bromovinblastine soaked (Tc)[2]R crystal after a low and a high dose of X-ray irradiation is shown in green (contoured at 5.5 ). c, Two perpendicular views of the vinblastine site. The labelled structural elements belong to the two domains that, together with a C-terminal helical hairpin, constitute the tubulin subunits. Loop T5 is part of the N-terminal 1 tubulin nucleotide-binding domain. Helix H6 and loop H6 -H7 link this domain to the intermediate domain. Helix H10, strand S9 and loop T7 are part of the 2 tubulin intermediate domain. Loops T5 and T7 contact the nucleotide in straight protofilaments.
Figure 3.
Figure 3: Kinetics of vinblastine binding to (Tc)[2]R.
 
  The above figures are reprinted by permission from Macmillan Publishers Ltd: Nature (2005, 435, 519-522) copyright 2005.  
  Figures were selected by the author.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21397191 A.Grafmüller, and G.A.Voth (2011).
Intrinsic bending of microtubule protofilaments.
  Structure, 19, 409-417.  
21082139 D.J.Edwards, J.A.Hadfield, T.W.Wallace, and S.Ducki (2011).
Tubulin-binding dibenz[c,e]oxepines as colchinol analogues for targeting tumour vasculature.
  Org Biomol Chem, 9, 219-231.  
21309084 H.Yang, A.Ganguly, S.Yin, and F.Cabral (2011).
Megakaryocyte lineage-specific class VI β-tubulin suppresses microtubule dynamics, fragments microtubules, and blocks cell division.
  Cytoskeleton (Hoboken), 68, 175-187.  
21381049 R.A.Stanton, K.M.Gernert, J.H.Nettles, and R.Aneja (2011).
Drugs that target dynamic microtubules: A new molecular perspective.
  Med Res Rev, 31, 443-481.  
19847777 A.Tripathi, and G.E.Kellogg (2010).
A novel and efficient tool for locating and characterizing protein cavities and binding sites.
  Proteins, 78, 825-842.  
20814887 C.M.Li, Y.Lu, S.Ahn, R.Narayanan, D.D.Miller, and J.T.Dalton (2010).
Competitive mass spectrometry binding assay for characterization of three binding sites of tubulin.
  J Mass Spectrom, 45, 1160-1166.  
20107862 D.Calligaris, P.Verdier-Pinard, F.Devred, C.Villard, D.Braguer, and D.Lafitte (2010).
Microtubule targeting agents: from biophysics to proteomics.
  Cell Mol Life Sci, 67, 1089-1104.  
20657644 E.Screpanti, S.Santaguida, T.Nguyen, R.Silvestri, R.Gussio, A.Musacchio, E.Hamel, and P.De Wulf (2010).
A screen for kinetochore-microtubule interaction inhibitors identifies novel antitubulin compounds.
  PLoS One, 5, e11603.  
20614032 G.V.Schimizzi, J.D.Currie, and S.L.Rogers (2010).
Expression levels of a kinesin-13 microtubule depolymerase modulates the effectiveness of anti-microtubule agents.
  PLoS One, 5, e11381.  
20639865 G.Xu, J.S.Paige, and S.R.Jaffrey (2010).
Global analysis of lysine ubiquitination by ubiquitin remnant immunoaffinity profiling.
  Nat Biotechnol, 28, 868-873.  
20030375 J.A.Smith, L.Wilson, O.Azarenko, X.Zhu, B.M.Lewis, B.A.Littlefield, and M.A.Jordan (2010).
Eribulin binds at microtubule ends to a single site on tubulin to suppress dynamic instability.
  Biochemistry, 49, 1331-1337.  
20147901 M.Kavallaris (2010).
Microtubules and resistance to tubulin-binding agents.
  Nat Rev Cancer, 10, 194-204.  
20978652 S.Rendine, S.Pieraccini, and M.Sironi (2010).
Vinblastine perturbation of tubulin protofilament structure: a computational insight.
  Phys Chem Chem Phys, 12, 15530-15536.  
20103599 S.Yin, R.Bhattacharya, and F.Cabral (2010).
Human mutations that confer paclitaxel resistance.
  Mol Cancer Ther, 9, 327-335.  
19131341 A.Cormier, M.J.Clément, M.Knossow, S.Lachkar, P.Savarin, F.Toma, A.Sobel, B.Gigant, and P.A.Curmi (2009).
The PN2-3 domain of centrosomal P4.1-associated protein implements a novel mechanism for tubulin sequestration.
  J Biol Chem, 284, 6909-6917.  
19117686 A.L.Risinger, F.J.Giles, and S.L.Mooberry (2009).
Microtubule dynamics as a target in oncology.
  Cancer Treat Rev, 35, 255-261.  
19161972 E.Wilcox, C.McGrath, A.V.Blokhin, R.Gussio, and E.Hamel (2009).
Evidence for a distinct ligand binding site on tubulin discovered through inhibition by GDP of paclitaxel-induced tubulin assembly in the absence of exogenous GTP.
  Arch Biochem Biophys, 484, 55-62.  
19674193 J.Wang, Y.Yin, H.Hua, M.Li, T.Luo, L.Xu, R.Wang, D.Liu, Y.Zhang, and Y.Jiang (2009).
Blockade of GRP78 sensitizes breast cancer cells to microtubules-interfering agents that induce the unfolded protein response.
  J Cell Mol Med, 13, 3888-3897.  
19497297 M.C.Edler, G.Yang, M.Katherine Jung, R.Bai, W.G.Bornmann, and E.Hamel (2009).
Demonstration of microtubule-like structures formed with (-)-rhazinilam from purified tubulin outside of cells and a simple tubulin-based assay for evaluation of analog activity.
  Arch Biochem Biophys, 487, 98.  
19050925 N.L.Giles, A.Armson, and S.A.Reid (2009).
Characterization of trifluralin binding with recombinant tubulin from Trypanosoma brucei.
  Parasitol Res, 104, 893-903.  
19212143 R.H.Dave, W.Saengsawang, J.Z.Yu, R.Donati, and M.M.Rasenick (2009).
Heterotrimeric G-proteins interact directly with cytoskeletal components to modify microtubule-dependent cellular processes.
  Neurosignals, 17, 100-108.  
19565362 R.H.Wade (2009).
On and around microtubules: an overview.
  Mol Biotechnol, 43, 177-191.  
19359244 T.Manna, D.A.Thrower, S.Honnappa, M.O.Steinmetz, and L.Wilson (2009).
Regulation of microtubule dynamic instability in vitro by differentially phosphorylated stathmin.
  J Biol Chem, 284, 15640-15649.  
18071633 A.Aggarwal, A.Kruczynski, A.Frankfurter, J.J.Correia, and S.Lobert (2008).
Murine leukemia P388 vinorelbine-resistant cell lines are sensitive to vinflunine.
  Invest New Drugs, 26, 319-330.  
18787557 A.Cormier, M.Marchand, R.B.Ravelli, M.Knossow, and B.Gigant (2008).
Structural insight into the inhibition of tubulin by vinca domain peptide ligands.
  EMBO Rep, 9, 1101-1106.
PDB codes: 3du7 3e22
18294653 C.A.Moores, and R.A.Milligan (2008).
Visualisation of a kinesin-13 motor on microtubule end mimics.
  J Mol Biol, 377, 647-654.  
18502809 E.R.Miraldi, P.J.Thomas, and L.Romberg (2008).
Allosteric models for cooperative polymerization of linear polymers.
  Biophys J, 95, 2470-2486.  
18588888 F.Devred, P.O.Tsvetkov, P.Barbier, D.Allegro, S.B.Horwitz, A.A.Makarov, and V.Peyrot (2008).
Stathmin/Op18 is a novel mediator of vinblastine activity.
  FEBS Lett, 582, 2484-2488.  
18070965 F.L.Henriquez, P.R.Ingram, S.P.Muench, D.W.Rice, and C.W.Roberts (2008).
Molecular basis for resistance of acanthamoeba tubulins to all major classes of antitubulin compounds.
  Antimicrob Agents Chemother, 52, 1133-1135.  
18756565 F.Zanella, A.Rosado, B.García, A.Carnero, and W.Link (2008).
Chemical genetic analysis of FOXO nuclear-cytoplasmic shuttling by using image-based cell screening.
  Chembiochem, 9, 2229-2237.  
18668125 K.Saikrishnan, S.P.Griffiths, N.Cook, R.Court, and D.B.Wigley (2008).
DNA binding to RecD: role of the 1B domain in SF1B helicase activity.
  EMBO J, 27, 2222-2229.
PDB codes: 3e1s 3k70
18766974 L.Hiser, B.Herrington, and S.Lobert (2008).
Effect of noscapine and vincristine combination on demyelination and cell proliferation in vitro.
  Leuk Lymphoma, 49, 1603-1609.  
18384115 P.Singh, K.Rathinasamy, R.Mohan, and D.Panda (2008).
Microtubule assembly dynamics: an attractive target for anticancer drugs.
  IUBMB Life, 60, 368-375.  
18175355 T.M.Cao, D.Durrant, A.Tripathi, J.Liu, S.Tsai, G.E.Kellogg, D.Simoni, and R.M.Lee (2008).
Stilbene derivatives that are colchicine-site microtubule inhibitors have antileukemic activity and minimal systemic toxicity.
  Am J Hematol, 83, 390-397.  
19012291 Y.Yamazaki, K.Kohno, H.Yasui, Y.Kiso, M.Akamatsu, B.Nicholson, G.Deyanat-Yazdi, S.Neuteboom, B.Potts, G.K.Lloyd, and Y.Hayashi (2008).
Tubulin photoaffinity labeling with biotin-tagged derivatives of potent diketopiperazine antimicrotubule agents.
  Chembiochem, 9, 3074-3081.  
17683277 B.Kappes, and P.Rohrbach (2007).
Microtubule inhibitors as a potential treatment for malaria.
  Future Microbiol, 2, 409-423.  
17627938 H.Yang, and F.Cabral (2007).
Heightened sensitivity to paclitaxel in Class IVa beta-tubulin-transfected cells is lost as expression increases.
  J Biol Chem, 282, 27058-27066.  
  19455242 J.T.Huzil, K.Chen, L.Kurgan, and J.A.Tuszynski (2007).
The Roles of beta-Tubulin Mutations and Isotype Expression in Acquired Drug Resistance.
  Cancer Inform, 3, 159-181.  
17284862 T.Usui (2007).
Actin- and microtubule-targeting bioprobes: their binding sites and inhibitory mechanisms.
  Biosci Biotechnol Biochem, 71, 300-308.  
17331586 Y.Yan, and K.Broadie (2007).
In vivo assay of presynaptic microtubule cytoskeleton dynamics in Drosophila.
  J Neurosci Methods, 162, 198-205.  
17683369 Z.Wang, P.A.McPherson, B.S.Raccor, R.Balachandran, G.Zhu, B.W.Day, A.Vogt, and P.Wipf (2007).
Structure-activity and high-content imaging analyses of novel tubulysins.
  Chem Biol Drug Des, 70, 75-86.  
16505102 C.Marchand, S.Antony, K.W.Kohn, M.Cushman, A.Ioanoviciu, B.L.Staker, A.B.Burgin, L.Stewart, and Y.Pommier (2006).
A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex.
  Mol Cancer Ther, 5, 287-295.  
16555127 C.Martínez-Campa, P.Casado, R.Rodríguez, P.Zuazua, J.M.García-Pedrero, P.S.Lazo, and S.Ramos (2006).
Effect of vinca alkaloids on ERalpha levels and estradiol-induced responses in MCF-7 cells.
  Breast Cancer Res Treat, 98, 81-89.  
16941085 E.J.Carpenter, J.T.Huzil, R.F.Ludueña, and J.A.Tuszynski (2006).
Homology modeling of tubulin: influence predictions for microtubule's biophysical properties.
  Eur Biophys J, 36, 35-43.  
16495041 E.Nogales, and H.W.Wang (2006).
Structural intermediates in microtubule assembly and disassembly: how and why?
  Curr Opin Cell Biol, 18, 179-184.  
16549346 E.Nogales, and H.W.Wang (2006).
Structural mechanisms underlying nucleotide-dependent self-assembly of tubulin and its relatives.
  Curr Opin Struct Biol, 16, 221-229.  
16895428 H.Ishikawa, G.I.Elliott, J.Velcicky, Y.Choi, and D.L.Boger (2006).
Total synthesis of (-)- and ent-(+)-vindoline and related alkaloids.
  J Am Chem Soc, 128, 10596-10612.  
16838365 H.Morii, Y.Shiraishi-Yamaguchi, and N.Mori (2006).
SCG10, a microtubule destabilizing factor, stimulates the neurite outgrowth by modulating microtubule dynamics in rat hippocampal primary cultured neurons.
  J Neurobiol, 66, 1101-1114.  
16893427 I.Divinski, M.Holtser-Cochav, I.Vulih-Schultzman, R.A.Steingart, and I.Gozes (2006).
Peptide neuroprotection through specific interaction with brain tubulin.
  J Neurochem, 98, 973-984.  
16554300 S.Honnappa, W.Jahnke, J.Seelig, and M.O.Steinmetz (2006).
Control of intrinsically disordered stathmin by multisite phosphorylation.
  J Biol Chem, 281, 16078-16083.  
17069528 S.Sengupta, and S.A.Thomas (2006).
Drug target interaction of tubulin-binding drugs in cancer therapy.
  Expert Rev Anticancer Ther, 6, 1433-1447.  
16990856 Y.Pommier (2006).
Topoisomerase I inhibitors: camptothecins and beyond.
  Nat Rev Cancer, 6, 789-802.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.